Scott Estes
Analyst · RBC Capital Markets
All right, thanks Scott and good morning everyone. We were pleased to generate another solid quarter of earnings results and operating performance that of our portfolio. I would like to focus my comments this morning on how we are thinking about our business from a financial perspective as we enter the second half of the year. As Tom and Scott mentioned we will not be shy about looking for incremental disposition opportunity throughout the remainder of 2016. As a result, you should expect us to remain focused around our capital allocation theme this year, which emphasizes the following three components. First, we will look to maximize our financial flexibility through enhance liquidity as evidenced by the recent increase in our line of credit from $2.5 billion to $3 billion. Second, we intent to further strengthen our balance sheet by using incremental disposition proceeds to fund announced investments and continue to reduce leverage and strengthen our credit metrics. And third, we intend to further enhance the quality of our portfolio through targeted asset sales which we will remain focused on reducing our skill nursing exposure and in increasing our private pay mix. So again, begin my detailed remarks with some perspective on our second quarter financial performance and several of the more significant changes made through our supplemental package this quarter. In terms of second quarter earnings, we generated normalized FFO of a $0.15 per share up about 6% versus last year and normalized that of a $1.4 per share, which increased 9% versus last year. Results were driven primarily by our same-store cash NOI growth and the $1.9 billion of net investments completed over the last four quarters. Overall I think this is a fairly straight forward quarterly report, as our net investment volume of $129 million was relatively light, a G&A of $39.9 million was in line with expectations, and tax expenses only quite less than expected. The only somewhat unusual item was on other income line which included an additional $11.8 million related to the receipt of insurance proceeds and the release of an escrow the benefit of both of which were backed out of our normalized earnings results. Moving onto dividends, we will pay our 181st consecutive quarterly cash dividend on August 22nd of $0.86 per share, a rate of $3.44 annually. This represents a 4.2% increase over the dividends paid last year and represents a current dividend yield of 4.3%. I'd also like to point out three fairly significant enhancements we made to our supplemental package this quarter. First, you can see at the bottom of page five that we enhanced our CapEx disclosure to include both recurring CapEx that impacts our normalized FAD, but also the other CapEx amounts that are generally the value enhancing larger renovation projects throughout portfolio. Second on page eight, we had a detailed trip-net payment coverage data that highlights both EBITDA coverage and duration of the individual leases in our portfolio. And third on page 29, we added disclosure related to our same-store NOI calculation methodology which details the specific adjustments to arrive at our same property count at the top of the page and the adjustments to arrive at the same-store NOI by property type at the bottom of the page. I think our intent here is to be as transparent as possible in showing you how we calculate our same-store result. Turning next to our liquidity picture and balance sheet, the second quarter was fairly quite from a capital markets activity prospective, I think the highlight of the quarter occurred in May, when we further enhanced our financial growth stability by increasing our line of credit from $2.5 billion to $3 billion, while extending the units of that improvement at 2020. Our new line is priced that LIBOR plus 90 basis points, represents saving of 2.5 basis points from our previous line and carry the one-year extension option and in accordion fees for additional $1 billion. This brings our total unsecured credit facilities at 3.7 billion, when including our U.S. dollar and Canadian dollar term loan which were also extended for another five years. In terms of equity, we raised $64 million by issuing 914,000 shares through to our [drip] (Ph) program this quarter and we also generated 227 million of proceeds for dispositions and loan payoff, which importantly included $61 million in Genesis mortgage loan repaid during the quarter. and lastly, repaid approximately $151 million of secured debt at a blended rate of 5.2% while issuing $87 million of secured debt at a blended rate at 3%. So as a result, we continue to have significant liquidity with over $2.7 billion available at quarter end, with only $745 million of line borrowing and $467 million in cash on balance sheet. Our balance sheet and financial metrics at the end of the second quarter remains strong, as of June 30, our net debts-to-undepreciated book cap of 39.2% improved 40 basis from last quarter, while net debt to enterprise value improved 230 basis points to 30%. Out net debt-to-adjusted EBITDA improved to 5.5 times, while our adjusted interest and fixed charge coverage for the quarter remains solid at 4.2 times and 3.2 times respectively. Our secured debt level remained at only 11.9% of total assets at quarter end. In addition, we are pleased to receive an upgrade in our senior debt rating from Moody’s to BAA1 in June. In light of the recent Brexit vote, I would like to take just a moment to remind you that we have fairly little financial exposure to the recent weakness in the pound sterling as a result of our hedging program. More specifically as of June 30, our UK exposure from a balance sheet prospective is over 80% hedge, through a combination of sterling denominates unsecured debt and other currencies hedges in place, while our earnings that at the UK are approximately 90% hedged, their interest expense on debt, G&A CapEx and cash flow hedge. Since the UK does represent only 8% of our total NOI, each 10% move in the pound against the dollar currently has an annualized earnings impact of less than $0.01 per year. I will conclude my comments today with an update on the key assumptions driving our 2016 guidance. Regarding investments, our acquisition guidance includes those completed during the first half of the year, the $1.1.5 billion Vintage portfolio, and an additional $48 million of investments expected to remain through partnership. Moving to depositions, we have increased our dispositions forecast for the full -ear to $1.3 billion in proceeds from the previous $1 billion. Our new forecast is comprised of the $343 million in proceeds received during the first half of the year. $769 million of proceeds from properties currently held-for-sale, with the reminder representing loan payoff and other potential property sales over the rest for the year. Most of the $300 million of incremental disposition proceed and they were added to our guidance this quarter of skilled nursing asset and do to include $68 million from our Genesis portfolio. As Tom and Scott mentioned, we continue to evaluate opportunities to sell additional Genesis assets above and beyond those included in our current guidance. And just to be clear, our exposure to Genesis has declined by $57 million for the three Genesis related items that have been disclosed over the past two days, which includes the $61 million in mortgage loans repaid during the quarter to $68 million in pending dispositions partially offset by the $72 million new term loan. In terms of our same-store NOI growth forecast, there is no change to our blended full-year estimate of 2.75% to 3.25% though I would state that we are attracting toward a higher end of the range at this point driven largely by the strength of our senior housing operating portfolio. Our FAD CapEx forecast is currently $82 million for 2016 comprised of approximately $55 million associated with the senior housing operating portfolio with the remaining $27 million coming from our outpatient medical portfolio. We do expect CapEx spending to ramp up a bit during the latter half of the year due to the timing of projected expenditures. Our G&A forecast continues to track towards the low end of our initial guidance at approximately $160 million for the full-year at this point. Our tax line item is projected to return to an expense of about $3 million to $4 million per quarter during the each of the last two quarters of this year based on slightly higher taxable income forecast. And a result of all of these assumptions we are maintaining our normalized FFO guidance of $4.50 to 44.60 per diluted share and FAD guidance of $3.95 to $4.05 per diluted share, both of which represents 3% to 5% growth over normalized 2015 results. I think our decision to maintain guidance was largely based on the fact that the incremental dispositions added to our guidance this quarter should be roughly offset by the Vintage portfolio acquisitions and continued solid operating portfolio performance through the second quarter. So in conclusion, we remain focused on our capital allocation efforts this year that we will continue to prioritize, maximizing financial flexibility through increased liquidity, strengthening our balance sheet by lowering leverage and enhancing the quality of our portfolio and private pay mix. So that concludes my remarks and I think at this point, Tom I will turn it to you for some closing comments.